28
Participants
Start Date
October 31, 2015
Primary Completion Date
September 1, 2019
Study Completion Date
September 1, 2019
abatacept also known as Orencia also known as CTLA4-Ig
125mg injected subcutaneously weekly for 16 weeks
Placebo
UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles
University of California, San Diego, San Diego
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
University of California, Los Angeles
OTHER